摘要
癌症是全球最具破坏性的疾病。天然产物具有优异的化学通用性、高分子特异性和低毒性等化学和生物特性,这使其成为新药研究的先导。这些植物化学物质不仅有助于预防而且还能治疗慢性癌症。本文试图从组学的角度筛选出具有组学特性和特异性抗癌活性的抗肿瘤植物化学物质。抗癌植物化学物质的靶部位传递和控释等问题一直是国内外医学研究人员关注的重点。最传统的治疗癌症的化疗方案会导致副作用,限制生物疗效和损害患者的预后。为了克服现有及未来天然抗癌药物的不足,实现疗效好、副作用少的靶向给药,新型纳米结构颗粒和纳米载体系统构成的纳米方法受到了特别关注。近年来,人们发现了介孔和纳米孔药物传递机制,如无机或有机基纳米海绵。金属基无机体系在体内表现出毒性和不可降解性。由于与无机系统相关的问题,研究从无机系统向有机纳米系统的重大转变已经发生。大约几十年前,研究人员开发了有机纳米海绵来控制药物输送和癌症治疗的局限性。本文就纳米海绵包覆植物化学物质在肿瘤治疗中的应用进展作一综述。
关键词: 纳米海绵,植物化学物质,癌症治疗,有机纳米系统,靶向药物传递,常规化疗,细胞毒性
图形摘要
Current Drug Targets
Title:Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Volume: 22 Issue: 4
关键词: 纳米海绵,植物化学物质,癌症治疗,有机纳米系统,靶向药物传递,常规化疗,细胞毒性
摘要: Cancer is the most ruinous disease globally. Natural products have impressive characteristics, such as exceptional chemical versatility, chemical and biological properties of macromolecular specificity and less toxicity which make them good leads in finding novel drugs. The phytochemicals not only help to prevent but also treat chronic cancerous conditions. The present review attempts to put forth some selected anticancer phytochemicals that had reported omics characteristic and specifically suppressed cancer with in vitro and in vivo activity. Certain issues pertaining to anticancer phytochemicals like delivery to target site in the body and achieving controlled release in order to prevent overdoses have been a major concern for medical researchers worldwide. The most conventional chemotherapy protocols for the treatment of cancer lead to adverse effects that limit biological efficacy and compromise patient outcomes. In order to defeat incompetency of current and upcoming natural anticancer agents and to attain targeted drug delivery with good efficacy and fewer side effects, there is a special focus on novel nanostructured particles and nano approaches consisting of carrier system. Recent studies have led to the discovery of mesoporous and nanoporous drug delivery mechanisms, such as inorganic or organic-based nanosponges. The metal based inorganic systems have exhibited toxicity and non-biodegradable character in vivo. As a result of problems related to inorganic systems, major shift of research from inorganic to organic nanosystems has occurred. About decades ago, researchers developed organic nanosponges to control the limitation of drug delivery and cancer therapies. This review article discusses the development and application of nanosponges encapsulated phytochemicals for cancer therapy.
Export Options
About this article
Cite this article as:
Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review, Current Drug Targets 2021; 22 (4) . https://dx.doi.org/10.2174/1389450121999201012201455
DOI https://dx.doi.org/10.2174/1389450121999201012201455 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Physicochemical Properties that Determine Cellular Transport of Nanocarriers In Vitro and In Vivo
Current Organic Chemistry P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Role of microRNAs in Gynecological Pathology
Current Medicinal Chemistry Molecular Imaging: Translation from Rats to Dogs and Humans
Current Medical Imaging Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH
Current Vascular Pharmacology Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology Bioprospecting for Functionally-Proficient Potential Probiotics
Current Nutrition & Food Science The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases
Current Genomics Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Current Pharmaceutical Design Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism
Current Pharmaceutical Design Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Multifunctional Nanoparticles, Nanocages and Degradable Polymers as a Potential Novel Generation of Non-Invasive Molecular and Cellular Imaging Systems
Recent Patents on Nanotechnology Cell Sheet-Based Myocardial Tissue Engineering: New Hope for Damaged Heart Rescue
Current Pharmaceutical Design Disulfiram's Anticancer Activity: Evidence and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Protective Role of Natural Products in Cisplatin-Induced Nephrotoxicity
Mini-Reviews in Medicinal Chemistry Cyclooxygenase-2 Inhibition and Gastric Cancer
Current Pharmaceutical Design Dendritic Cells and their Receptors in Antitumor Immune Response
Current Molecular Medicine GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?
Current Topics in Medicinal Chemistry Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents
Current Medicinal Chemistry